R. Jayachandra Babu

Cited by

	All	Since 2020
Citations	4776	2844
h-index	37	25
i10-index	94	70

800

400

200

600

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520 26 44 59 63 86 123 112 132 139 139 154 172 193 192 234 318 455 543 628 796 100

Public access

View all

23 articles

2 articles

available

not available

Based on funding mandates

Co-authors

Amit K. TiwariProfessor and Associate Dean, College of Pharmacy,University of Arkansas for Medical Sciences (UAMS)Verified email at uams.edu
Mandip Singh SachdevaProfessor, FAMU College of PharmacyVerified email at famu.edu
Manjusha AnnajiFood and Drug AdministrationVerified email at fda.hhs.gov
Sai Hanuman Sagar BodduProfessor of Pharmaceutics, Ajman UniversityVerified email at ajman.ac.ae
Ishwor PoudelPostdoctoral ORISE Fellow (FDA/CDER), Auburn UniversityVerified email at auburn.edu
Robert D Arnold "Rusty"Professor and Director of Research, Auburn UniversityVerified email at auburn.edu
Ranjeet DashSenior Principal Scientist, The Janssen Pharmaceutical Companies of Johnson & JohnsonVerified email at its.jnj.com
sateesh kumar sathigariPatheon PharmaceuticalsVerified email at Patheon.com
Muralikrishnan DhanasekaranAuburn UniversityVerified email at auburn.edu
Rabin NeupaneUniversity of ToledoVerified email at rockets.utoledo.edu
Vijay RangariTuskegee UniversityVerified email at tuskegee.edu
Kasturi Pawar, PhDAuburn UniversityVerified email at auburn.edu
hamad alrbyawiTaibah UniversityVerified email at taibahu.edu.sa
Gurkishan Singh ChadhaUniversity of New England, MaineVerified email at une.edu
Xuejia KangAuburn universityVerified email at auburn.edu
Forrest SmithProfessor or Drug Discovery and Development, Auburn UniversityVerified email at auburn.edu
Nur MitaDepartment of Pharmaceutical Sciences, Mulawarman University, IndonesiaVerified email at farmasi.unmul.ac.id
Srinath PalakurthiTexas A&M Health Science Center College of PharmacyVerified email at tamhsc.edu
Dr. Rishi PaliwalAssociate Professor, Indira Gandhi National Tribal University, Amarkantak, MP, IndiaVerified email at igntu.ac.in
Maria Soledad PeresinAssociate Professor Biomaterials chemistry and nanotechnology, Auburn UniversityVerified email at auburn.edu

R. Jayachandra Babu

Other namesRamapuram Jayachandra Babu, Jayachandra Babu Ramapuram, Jay Ramapuram

Auburn University, Harrison Collge of Pharmacy

Verified email at auburn.edu

transdermal solubility cyclodextrins 3D printing nanoparticles


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Nanomedicine scale-up technologies: feasibilities and challenges R Paliwal, RJ Babu, S Palakurthi Aaps Pharmscitech 15 (6), 1527-1534, 2014	390	2014
Alternatives to biological skin in permeation studies: Current trends and possibilities R Neupane, SHS Boddu, J Renukuntla, RJ Babu, AK Tiwari Pharmaceutics 12 (2), 152, 2020	284	2020
Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement SK Sathigari, VK Radhakrishnan, VA Davis, DL Parsons, RJ Babu Journal of pharmaceutical sciences 101 (9), 3456-3464, 2012	171	2012
Role of cyclodextrins in nanoparticle-based drug delivery systems H Shelley, RJ Babu Journal of pharmaceutical sciences 107 (7), 1741-1753, 2018	165	2018
Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ... Aaps Pharmscitech 10, 81-87, 2009	125	2009
Resveratrol‐loaded nanomedicines for cancer applications M Annaji, I Poudel, SHS Boddu, RD Arnold, AK Tiwari, RJ Babu Cancer reports 4 (3), e1353, 2021	124	2021
Formulation of controlled release gellan gum macro beads of amoxicillin RJ Babu, S Sathigari, MT Kumar, JK Pandit Current drug delivery 7 (1), 36-43, 2010	123	2010
In vitro and in vivo evaluation of topical formulations of spantide II L Kikwai, RJ Babu, R Prado, A Kolot, CA Armstrong, JC Ansel, M Singh Aaps Pharmscitech 6, E565-E572, 2005	118	2005
Biomaterial‐Derived Calcium Carbonate Nanoparticles for Enteric Drug Delivery D Render, T Samuel, H King, M Vig, S Jeelani, RJ Babu, V Rangari Journal of nanomaterials 2016 (1), 3170248, 2016	93	2016
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size … P Dayal, V Pillay, RJ Babu, M Singh Aaps Pharmscitech 6, E573-E585, 2005	92	2005
Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems RJ Babu, JK Pandit International journal of pharmaceutics 288 (2), 325-334, 2005	92	2005
Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit International journal of pharmaceutics 271 (1-2), 155-165, 2004	92	2004
Formulation and in vitro evaluation of transdermal patches of melatonin N Kanikkannan, S Andega, S Burton, RJ Babu, M Singh Drug development and industrial pharmacy 30 (2), 205-212, 2004	92	2004
Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: an insight from the published in vitro, preclinical and clinical studies RP Dash, R Jayachandra Babu, NR Srinivas European journal of drug metabolism and pharmacokinetics 42, 915-933, 2017	90	2017
Lipid materials for topical and transdermal delivery of nanoemulsions KR Pawar, RJ Babu Critical Reviews™ in Therapeutic Drug Carrier Systems 31 (5), 2014	80	2014
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro L Kikwai, N Kanikkannan, RJ Babu, M Singh Journal of controlled release 83 (2), 307-311, 2002	78	2002
Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics RP Dash, RJ Babu, NR Srinivas Clinical pharmacokinetics 57, 1385-1398, 2018	74	2018
Critical assessment of pharmacokinetic drug–drug interaction potential of tofacitinib, baricitinib and upadacitinib, the three approved janus kinase inhibitors for rheumatoid … V Veeravalli, RP Dash, JA Thomas, RJ Babu, LMV Madgula, NR Srinivas Drug safety 43, 711-725, 2020	63	2020
Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit Drug Delivery 12 (3), 165-169, 2005	63	2005
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 … RP Dash, RJ Babu, NR Srinivas Xenobiotica 48 (1), 89-108, 2018	62	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors